Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsOPHTHALMICGeneric

BIMATOPROST

BIMATOPROST

Standard Dose
0.03
Max Dose
Refer to approved labeling
Primary Use
Marketing status: None (Tentative Approval)
Summary

Approval overview BIMATOPROST is listed in Drugs@FDA under application 200487 (ANDA).

Marketing status: None (Tentative Approval) Active ingredient BIMATOPROST Form and strength SOLUTION; OPHTHALMIC - 0.03 Sponsor SANDOZ Submission history Latest submission status date: 2011-04-18 00:00:00.

Structured Monograph

Clinical summary

Approval overview BIMATOPROST is listed in Drugs@FDA under application 200487 (ANDA). Marketing status: None (Tentative Approval) Active ingredient BIMATOPROST Form and strength SOLUTION; OPHTHALMIC - 0.03 Sponsor SANDOZ Submission history Latest submission status date: 2011-04-18 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: None (Tentative Approval)

Interaction Notes

  • No interaction notes stored yet.